TIS 0.00% 0.0¢ tissue therapies limited

scandal, page-21

  1. 1,408 Posts.
    lightbulb Created with Sketch. 6
    Further to my post above:
    I ended it without clarifying how I see the regulatory concerns.
    TIS either settled for a non- binding classification of the product or something has changed for the original classification to be under review.

    Public servants do not take such decision lightly because of the inevitable criticism drawn to their ministries as has been vehemently displayed here.
    These are career limiting moves if such delays are actually frivolous or factually inconsequential.

    Threat of legal action is always foremost in the minds of regulators, and therefore we cannot dismiss TIS culpability here, in the absence of TIS threatening legal action.
    Any way I look at it there is only one conclusion -TIS management cannot caste themselves as innocent victims or completely blameless in this latest saga.
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.